Zhaoqian Q. Gong

Guangzhou, 510515, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Histidine metabolic reprogramming drives oxidative stress induced mtDNA release to promote necroptosis and airway inflammation in severe asthma.

Histidine metabolic reprogramming drives oxidative stress induced mtDNA release to promote necroptosis and airway inflammation in severe asthma.

Journal: Redox biology
Published: June 23, 2026

Cannabichromeorcin targets cathepsin L to alleviate oxidative stress-Driven airway inflammation in severe asthma.

Cannabichromeorcin targets cathepsin L to alleviate oxidative stress-Driven airway inflammation in severe asthma.

Journal: Redox biology
Published: March 07, 2026

Nrp1 Signaling Reprograms Glutathione Metabolism to Drive Mitochondrial Dysfunction in Severe Asthma.

Nrp1 Signaling Reprograms Glutathione Metabolism to Drive Mitochondrial Dysfunction in Severe Asthma.

Journal: Antioxidants (Basel, Switzerland)
Published: February 22, 2026

The Adherence Paradox in Uncontrolled Moderate-To-Severe Asthma: A Qualitative Study of Patient Experiences and Unmet Needs.

The Adherence Paradox in Uncontrolled Moderate-To-Severe Asthma: A Qualitative Study of Patient Experiences and Unmet Needs.

Journal: Research in nursing & health
Published: February 03, 2026

Type 2 biomarkers outperform asthma-COPD overlap definitions in predicting clinical outcomes in COPD patients initiating triple therapy: A prospective cohort study.

Type 2 biomarkers outperform asthma-COPD overlap definitions in predicting clinical outcomes in COPD patients initiating triple therapy: A prospective cohort study.

Journal: Respiratory medicine
Published: December 24, 2025

Clinical characteristics, symptom burden, and pulmonary function trajectories of spirometry- and MMEF-defined bronchodilator responsiveness in COPD: a single-center prospective study.

Clinical characteristics, symptom burden, and pulmonary function trajectories of spirometry- and MMEF-defined bronchodilator responsiveness in COPD: a single-center prospective study.

Journal: Journal of thoracic disease
Published: December 17, 2025

Short-term longitudinal variation in exhaled nitric oxide fraction predicts future moderate-to-severe exacerbations in COPD patients on triple therapy: a prospective cohort study.

Short-term longitudinal variation in exhaled nitric oxide fraction predicts future moderate-to-severe exacerbations in COPD patients on triple therapy: a prospective cohort study.

Journal: ERJ open research
Published: December 12, 2025

Sputum Eosinophils Predict Annual Remission of the Frequent Exacerbator Phenotype in COPD: A Prospective Cohort Study.

Sputum Eosinophils Predict Annual Remission of the Frequent Exacerbator Phenotype in COPD: A Prospective Cohort Study.

Journal: Lung
Published: November 12, 2025

Characteristics of type 2 inflammation in nocturnal asthma and evaluation of the effectiveness of inhaled corticosteroids combination therapy

Characteristics of type 2 inflammation in nocturnal asthma and evaluation of the effectiveness of inhaled corticosteroids combination therapy

Journal: Zhonghua yi xue za zhi
Published: January 14, 2025

YTHDF1-mediated mitochondrial dysfunction and allergic airway inflammation by interaction with β-catenin/TCF4 signaling.

YTHDF1-mediated mitochondrial dysfunction and allergic airway inflammation by interaction with β-catenin/TCF4 signaling.

Journal: International immunopharmacology
Published: January 03, 2025

High Anxiety in COPD: A Barrier to Effective Inhaler Medication Adherence and Disease Management.

High Anxiety in COPD: A Barrier to Effective Inhaler Medication Adherence and Disease Management.

Journal: Journal of clinical nursing
Published: December 04, 2024

Bongkrekic acid alleviates airway inflammation via breaking the mPTP/mtDAMPs/RAGE feedback loop in a steroid-insensitive asthma model.

Bongkrekic acid alleviates airway inflammation via breaking the mPTP/mtDAMPs/RAGE feedback loop in a steroid-insensitive asthma model.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 11, 2024
Showing 1-12 of 18

Last Updated: 09/26/2026